Immune response against 3LL Lewis lung carcinoma potentiates the therapeutic efficacy of endostatin: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

    12 August 2022

    • curprev 17:0317:03, 12 August 2022‎ 187.21.138.9 talk‎ 498 bytes +498‎ Created page with "== Target Article == Immune response against 3LL Lewis lung carcinoma potentiates the therapeutic efficacy of endostatin; M Li, X Huang, Z Zhu, M Wong, S Watkinsae; 2001; doi_citing_unknown == Retraction == CTL Induction by a Tumour-associated Antigen Octapeptide Derived From a Murine Lung Carcinoma ; Ofer Mandelboim Gideon Berke Mati Fridkin Michael Feldman Miriam Eisenstein Lea Eisenbach; 12/11/1997 ; https://doi.org/10.1038/37678 == Citation piece == Note: Open..."
Retrieved from "https://wikicitingretracted.org/index.php?title=Immune_response_against_3LL_Lewis_lung_carcinoma_potentiates_the_therapeutic_efficacy_of_endostatin"